Anestacon
Product Images NDC 50383-772

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Anestacon (NDC 50383-772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hi-tech Pharmacal Co., Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Anestacon 01)

Chemical structure of Anestacon active ingredient showing a toluene ring with two methyl groups, an amide linkage to an ethylated amine, and association with hydrochloride (HCl).*

FDA Label Image

Principal Display Panel (15 mL Bottle Carton)

Packaging label for Anestacon Lidocaine Hydrochloride Jelly USP, 2%, by Hi-Tech Pharmacal Co., Inc. The label states the product is a 15 mL sterile aqueous topical jelly containing lidocaine hydrochloride and other ingredients, intended for prescription use only. Usage instructions and storage conditions at controlled room temperature (20°-25°C) are included. The label includes the NDC 50383-772-15 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.